• Sponsored Content

Single-Cell Dispensing for Cell Line Development and Single-Cell Genomics: Most Trusted Technology for Assuring Monoclonality by the Pharmaceutical Industry

Fabian Stumpf

August 1, 2019

1 Min Read

Cytena_c_REV-300x155.jpgClonal cell line development is a crucial step in a number of applications, including generating biopharmaceuticals (e.g., monoclonal antibodies, MAbs). Current workflows in cell line development have major drawbacks such as missing proof of clonality, inefficient single-cell isolation, and reduced cell viability. The single-cell printer™ technology offers documented assurance of clonality and provides efficient and fast single-cell seeding combined with excellent cell viability and zero risk of cross-contamination. All cytena products support SLAS/SBS format 96-well and 384-well plates. Different typical cell lines used in cell line development such as CHO-K1, HEK 293, L929 can be processed.

Fill out the form below to read the complete capabilities review now.

You May Also Like